951626-95-2
951626-95-2 结构式
基本信息
4-氧代-4,5,6,7-四氢吡唑并[1,5-A]吡嗪-2-羧酸乙酯
乙基 4-氧亚基-4H,5H,6H,7H-吡唑并[1,5-A]吡嗪-2-甲酸基酯
吡唑并[1,5-A]吡嗪-2-甲酸, 4,5,6,7-四氢-4-氧代-, 乙基 酯
4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate
ethyl 4-oxo-6,7-dihydro-5H-pyrazolo[1,5-a]pyrazine-2-carboxylate
PYRAZOLO[1,5-A]PYRAZINE-2-CARBOXYLIC ACID, 4,5,6,7-TETRAHYDRO-4-OXO-, ETHYL ESTER
物理化学性质
制备方法
1380507-24-3
951626-95-2
在氮气氛围下,将1-(3-叔丁氧基羰基氨基乙基)-1H-吡唑-3,5-二羧酸二乙酯(2.4 g,6.7 mmol)溶解于4 N盐酸的二恶烷溶液(25 mL)中。反应混合物于室温搅拌1小时后,用饱和碳酸钠溶液碱化,并用二氯甲烷萃取。分离有机相,用饱和食盐水洗涤,无水硫酸钠干燥,过滤后减压浓缩溶剂。粗产物通过快速柱色谱法纯化(硅胶为固定相,洗脱剂为二氯甲烷/含7 M氨的甲醇溶液,梯度从0/100至5/95)。收集目标组分,减压除去溶剂,得到4-氧代-4,5,6,7-四氢吡唑并[1,5-a]吡嗪-2-羧酸乙酯(1.1 g,产率79%)为白色固体。化合物分子式为C9H11N3O3,LCMS分析结果:保留时间0.49分钟,质荷比m/z 210 [M+H]+(参考LCMS方法1)。
参考文献:
[1] Patent: WO2012/78817, 2012, A1. Location in patent: Page/Page column 140
[2] Patent: WO2012/83224, 2012, A1. Location in patent: Page/Page column 266
[3] Patent: WO2013/192350, 2013, A1. Location in patent: Paragraph 00591
[4] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 2, p. 429 - 434
[5] Patent: US2015/361081, 2015, A1. Location in patent: Paragraph 0480
